Galilei Biosciences
Drug development company targeting PARP1, a central regulator of DNA damage repair, glucose and lipid metabolism, to develop therapies for metabolic health and human longevity.
Website
https://www.galileibio.comLocation
Boston, Massachusetts, USA
Founded
2021
Investors
1
Categories
biotech, longevity, metabolic-health, cardiovascular, drug-discovery
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apollo Health Ventures | Dusseldorf, Germany / Boston, USA | biotech-focused | seedseries-a+1 | 15 |